Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03176849 · ClinicalTrials.gov registry record · Phase 4
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
A Phase 4 study of Myelodysplastic Syndromes and Pediatric Cancer, sponsored by Phoenix Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 49
- Enrollment target
- 1
- Study location
NCT03176849 is a Phase 4 study of Myelodysplastic Syndromes and Pediatric Cancer that has completed, run by Phoenix Children's Hospital. The registered enrollment target is 49 participants, below the 285-participant average among 173 other Myelodysplastic Syndromes trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03176849, a Phase 4 study of Myelodysplastic Syndromes and Pediatric Cancer, has completed, sponsored by Phoenix Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
Research has suggested that children with sufficient vitamin D levels undergoing hematopoietic stem cell transplant (HSCT) have improved outcomes, including lower incidences of infection and graft-versus-host disease (GVHD), as well as overall improved survival. However, supplementation in children undergoing HSCT has shown to be a challenge using standard or aggressive supplementation strategies. The primary objective of this study is to determine the safety and efficacy of a single, high dose oral vitamin D (Stoss Therapy) at the start of transplant followed by maintenance supplementation in children undergoing HSCT.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Standard Vitamin D3 Supplementation
Study Locations (1)
Arizona
- Phoenix Children's Hospital - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2019-07-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03176849
The ClinicalTrials.gov registry entry for NCT03176849 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 285-participant average among 173 other Myelodysplastic Syndromes trials with a reported enrollment target (83% lower). The listed sponsor is Phoenix Children's Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Myelodysplastic Syndromes appearing as the primary indexed condition, and to 2 interventions - of which Vitamin D3 is the first listed.
NCT03176849 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT03176849 about?
NCT03176849 is a clinical study titled "A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT". Research has suggested that children with sufficient vitamin D levels undergoing hematopoietic stem cell transplant (HSCT) have improved outcomes, including lower incidences of infection and graft-versus-host disease (GVHD), as well as overall improved survival. However, supplementation in children ...
What is the current status of trial NCT03176849?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2017-11-01. Estimated completion is 2019-07-01.
What conditions does trial NCT03176849 study?
This clinical trial studies the following conditions: Myelodysplastic Syndromes, Pediatric Cancer, Vitamin D Deficiency, Aplastic Anemia, Stem Cell Transplant Complications.
What interventions are being tested in trial NCT03176849?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Standard Vitamin D3 Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03176849?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03176849 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myelodysplastic Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETED · Phase 4
-
A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
RECRUITING · Phase 2
-
Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations
RECRUITING · Phase 2
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
-
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RECRUITING · Phase 2
-
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.